"I am pleased to have the opportunity to work with Covance's talented management team and partner with Joe Herring in my new role," Mr. Barr said. "The market opportunities of the drug development industry today are outstanding. I am committed to furthering our focus on operational excellence and deepening strategic partnerships with our clients to help them bring new medicines to market sooner."
"I am also looking forward to working with Mike in his new role overseeing the preclinical laboratory operations in North America," said Mr. Barr. "He has done a tremendous job of focusing on the growth and expansion of our Madison facility and his appointment will allow us to continue to build on the operational rigor we have put in place, and strengthen our ability to execute and deliver against our clients' needs."
Mr. Lehmann joined Covance assuming the role of General Manager of the Madison facility in 2005. Before joining Covance, Mike spent 17 years at GE's Healthcare business in key operational and management roles. He holds a B.S. in Mechanical Engineering from the Catholic University of America and an M.B.A. from Marquette University.
Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with revenues over the last twelve months of approximately $1.5 billion, global operations in more than 20 countries, and approximately 8,700 employees worldwide. Information on products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com
Statements contained in this press release, which are not historical
facts, such as statements about prospective earnings, savings, revenue,
operations, revenue and earnings grow
|SOURCE Covance Inc.|
Copyright©2007 PR Newswire.
All rights reserved